200 KRW
−10.38 B KRW
192.67 B KRW
13.82 M
About SAM CHUN DANG PHARM CO. LTD
Sector
CEO
In-Seok Jeon
Headquarters
Hwaseong-si
Website
Founded
1943
ISIN
KR7000250001
FIGI
BBG000CBJVQ4
SAM CHUN DANG PHARM Co., Ltd. engages in the manufacture and sale of pharmaceuticals. Its products include antibiotics, cures for the circulatory and respiratory system, medicines for the digestive system and ophthalmology, and anti-inflammatory. The company was founded on December 29, 1943 and is headquartered in Hwaseong-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 000250 is 141,000 KRW — it has decreased by −8.14% in the past 24 hours. Watch SAM CHUN DANG PHARM CO. LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SAM CHUN DANG PHARM CO. LTD stocks are traded under the ticker 000250.
000250 stock has risen by 35.32% compared to the previous week, the month change is a 25.33% rise, over the last year SAM CHUN DANG PHARM CO. LTD has showed a 98.31% increase.
000250 reached its all-time high on Jul 10, 2024 with the price of 230,000 KRW, and its all-time low was 1,000 KRW and was reached on Oct 28, 2008. View more price dynamics on 000250 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
000250 stock is 19.81% volatile and has beta coefficient of 1.44. Track SAM CHUN DANG PHARM CO. LTD stock price on the chart and check out the list of the most volatile stocks — is SAM CHUN DANG PHARM CO. LTD there?
Today SAM CHUN DANG PHARM CO. LTD has the market capitalization of 3.28 T, it has increased by 34.77% over the last week.
Yes, you can track SAM CHUN DANG PHARM CO. LTD financials in yearly and quarterly reports right on TradingView.
000250 net income for the last quarter is −1.11 B KRW, while the quarter before that showed 174.06 M KRW of net income which accounts for −738.44% change. Track more SAM CHUN DANG PHARM CO. LTD financial stats to get the full picture.
As of Dec 25, 2024, the company has 408.00 employees. See our rating of the largest employees — is SAM CHUN DANG PHARM CO. LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SAM CHUN DANG PHARM CO. LTD EBITDA is 14.03 B KRW, and current EBITDA margin is 9.38%. See more stats in SAM CHUN DANG PHARM CO. LTD financial statements.
Like other stocks, 000250 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SAM CHUN DANG PHARM CO. LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SAM CHUN DANG PHARM CO. LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SAM CHUN DANG PHARM CO. LTD stock shows the strong buy signal. See more of SAM CHUN DANG PHARM CO. LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.